MedTrace Logo

Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain

NCT07138781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-02-27

No results posted yet for this study

Summary

The aim of this study is to evaluate the role of ketamine as an adjuvant in external oblique intercostal plane block for post thoracotomy pain.

Conditions

  • Ketamine
  • Adjuvant
  • External Oblique Intercostal Plane Block
  • Thoracotomy
  • Pain

Interventions

DRUG

Ketamine

Patients will receive 29 ml bupivacaine 0.25% + 1 ml ketamine (50 mg).

DRUG

29 ml bupivacaine 0.25% + 1 ml saline

Patients will receive 29 ml of bupivacaine 0.25% + 1 ml of saline.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-23
Primary Completion
2026-02-17
Completion
2026-02-17

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07138781 on ClinicalTrials.gov